Vaccinated Becoming Persons of Interest

by Dr. Peter McCullough | Aug 23, 2021

 As the Delta outbreak rages on in many countries, experts are surprised by how high the peak is going to be for the present wave of cases. Fortunately, mortality rates which typically lag for several weeks, are staying far below prior rates with the prior variants as a testimony to the lower virulence of the Delta variant. However, given the mass of infected people in so many countries, the impact on hospitalization and death should not be underestimated, particularly with the lack of early treatment, which is a standard in so many countries.

Our CDC director and recent studies

[comments by director Walenski and research by Farinholt and colleagues]

have shown that the vaccinated not only can become ill will COVID-19 in the setting of vaccine failure, but they can also carry the virus in very high viral loads in the early symptomatic phase and, in this context, can become individual super-spreaders. So indeed, we are in a crisis of the vaccinated, who are directionally having lower rates of COVID-19 illness but passing it to unvaccinated victims who develop the syndrome. 

According to the Trusted News Initiative and the CDC, the media narrative is that the Delta outbreak is a “crisis of the unvaccinated.” Never has the world felt a crisis that has been self-created and self-imposed. 

In many ways, the pandemic response has been more injurious than the respiratory infection itself.

This week we have a terrific program with the hard science of Fernando Kreutz. M.D., Ph.D., of  FK Biotecnologia in Porto Alegre in Brazil who will do a deep dive into the spike protein, epitopes, and antibody responses. On the backside, we have a complete opposite view of the biotechnology complex in “Kedarji,” who is both a spiritual leader, as well as a holistic health and well-being practitioner and research scientist who has made the commitment to do all he can from his center in Ohio. He is making waves at the state level for “alternative” and allopathic approaches in the early treatment of COVID-19 to prevent hospitalization and death.